BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday

U.S. stocks were higher, with the Dow Jones index gaining more than 400 points on Monday.

On Friday, the FDA approved BridgeBio Pharma's Attruby (acoramidis), an orally-administered near-complete (≥90%) stabilizer of Transthyretin (TTR) for adults with ATTR-CM to reduce cardiovascular death and cardiovascular-related hospitalization. Also, HC Wainwright maintained a Buy rating on the stock and raised its price target from $43 to $49.

BridgeBio Pharma shares jumped 22.3% to $28.64 on Monday.

Here are some other big stocks recording gains in today's session.

Now Read This:

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.